Lipid nanoparticle (lnp) composition or formulation for nucleic acid therapeutics
AssigneePopVax Private Limited
InventorSourav Chattopadhyay
Life of this patent
Estimating the term…
Abstract
The present disclosure relates generally to lipid nanoparticle compositions comprising a nucleic acid, an ionizable polymer, a cationic lipid, a phospholipid, a sterol, and a PEG-lipid. Further, the present disclosure relates generally to methods of treating or preventing a disease, comprising administering to a subject in need thereof a lipid nanoparticle composition described herein.
Claims31
A lipid nanoparticle composition comprising:
- a. a nucleic acid,
- b. an ionizable polymer,
- c. a cationic lipid,
- d. a phospholipid,
- e. a sterol, and
- f. a PEG-lipid.
The lipid nanoparticle composition according to any one of the preceding claims, wherein the ionizable polymer is present in an amount from 1 mol percent to 25 mol percent.
The lipid nanoparticle composition according to any one of the preceding claims, wherein the cationic lipid is present in an amount from 25 mol percent to 50 mol percent.
The lipid nanoparticle composition according to any one of the preceding claims, wherein the cationic lipid is N,N-dioleyl-N,Ndimethylammonium chloride (DODAC);
- N-(2,3-dioleyloxy)propyl)-N,N,Ntrimethylammonium chloride (DOTMA);
- N,N-distearyl-N,N-dimethylammonium bromide (DDAB);
- N-(2,3dioleoyloxy)propyl)-N,N,N-trimethylammonium chloride (DOTAP);
- 3-(N—(N′,N′dimethylaminoethane)-carbamoyl)cholesterol (DC-Chol), N-(1-(2,3-dioleoyloxy)propyl)N-2-(sperminecarboxamido)ethyl)-N,N-dimethylammoniumtrifluoracetate (DOSPA), dioctadecylamidoglycyl carboxyspermine (DOGS), 1,2-dioleoyl-3-dimethylammonium propane (DODAP), N,N-dimethyl-2,3-dioleoyloxy)propylamine (DODMA), N-(1,2-dimyristyloxyprop-3-yl)-N,N-dimethyl-N-hydroxyethyl ammonium bromide (DMRIE), 1,2-dilinoleyloxy-N,N-dimethylaminopropane (DLin-DMA), 3-dimethylamino-2-(cholest-5-en-3-beta-oxybutan-4-oxy)-1-(cis,cis-9,12-oc-tadecadienoxy)propane (Clin-DMA), 2-[5′-(cholest-5-en-3-beta-oxy)-3′-oxapentoxy)-3-dimethyl-1-(cis,cis-9′,12′-octadecadienoxy)propane (CpLin-DMA), 2,3-Dilinoleoyloxy-N,N-dimethylpropylamine (DLin-DAP), 1,2-N,N′-Dilinoleylcarbamyl-3-dimethylaminopropane (DLincarb-DAP), 1,2-Dilinoleoylcarbamyl-3-dimethylaminopropane (DLin-CDAP), 2,2-dilinoleyl-4-dimethylaminomethyl-[1,3]-dioxolane (DLin-K-DMA), heptatriaconta-6,9,28,31-tetraen-19-yl 4-(dimethylamino)butanoate (DLin-MC3-DMA), heptadecan-9-yl 8-[2-hydroxyethyl-(6-oxo-6-undecoxyhexyl)amino]octanoate (SM-102), 6-[6-(2-hexyldecanoyloxy)hexyl-(4-hydroxybutyl)amino]hexyl 2-hexyldecanoate (ALC-0315), and nonyl 8-[(8-heptadecan-9-yloxy-8-oxooctyl)-(2-hydroxyethyl)amino]octanoate (SLP-0001).
The lipid nanoparticle composition according to any one of the preceding claims, wherein the cationic lipid comprises an ionizable lipid.
The lipid nanoparticle composition according to any one of the preceding claims, wherein the phospholipid is present in an amount from 2 mol percent to about 20 mol percent.
The lipid nanoparticle composition according to any one of the preceding claims, wherein the sterol is present in an amount from 30 mol percent to about 65 mol percent.
The lipid nanoparticle composition according to any one of the preceding claims, wherein the sterol is cholesterol, sitosterol, fecosterol, ergosterol, campesterol, stigmasterol, 5α-cholestanol, 5β-coprostanol, cholesteryl-(2′-hydroxy)-ethyl ether, cholesteryl-(4′-hydroxy)-butyl ether, 6-ketocholestanol, 5α-cholestane, cholestenone, 5α-cholestanone, 5β-cholestanone, cholesteryl decanoate, or their derivatives.
The lipid nanoparticle composition according to any one of the preceding claims, wherein the PEG-lipid is present in an amount from 0.2 mol percent to about 2.0 mol percent.
The lipid nanoparticle composition according to any one of the preceding claims, wherein the PEG-lipid is mPEG-Dimyristoyl glycerol (mPEG-DMG), mPEG-N,N-Ditetradecylacetamide (mPEG-DTA or ALC0159), mPEG-Cholesterol (mPEG-CLS), mPEG-DSPE, mPEG-DMPE, mPEG-DPPE, mPEG-DLPE, mPEG-DOPE, mPEG-DPPC, mPEG-DSPC, 1,2-Distearoyl-sn-Glycero-3-Phosphoethanolamine with conjugated methoxyl poly(ethylene glycol) (mPEG-DSPE), 1,2-dimyristoyl-rac-glycero-3-methoxypolyethylene glycol-2000 (DMG-PEG 2000), or mixtures thereof.
The lipid nanoparticle composition according to any one of the preceding claims, wherein the nucleic acid encodes an antigenic polypeptide or regulate or module a cellular function.
The lipid nanoparticle composition according to any one of the preceding claims, wherein the nucleic acid comprise at least one chemical modification.
A nucleic acid vaccine comprising the lipid nanoparticle composition according to any one of the preceding claims.
Dependencies are inferred from the claim text.